Clinical Trial Update: First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients With Superficial Femoral Artery Disease and/or Proximal Popliteal Artery Disease [NA]

View source ↗

Summary

This entry notes a first-in-human study to assess the safety and efficacy of the ChampioNIR drug-eluting peripheral stent for superficial femoral artery stenosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease
• Popliteal Artery Stenosis
• Superficial Femoral Artery Stenosis

Drugs mentioned

• ChampioNIR Drug Eluting Peripheral Stent

Snippet

Sponsor: Medinol Ltd. | Conditions: Superficial Femoral Artery Stenosis, Popliteal Artery Stenosis | NA | Status: RECRUITING